Atlas Trials

Galecto Biotech AB

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Galecto Biotech AB

RecordFirmDate
ENLIGHT-AML - An Open-label, Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT07084584)Galecto Biotech AB2026-06-10
A Study to Compare Pharmacokinetics of GB1211 (NCT05747573)Galecto Biotech AB2023-01-03
A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC). (NCT05240131)Galecto Biotech AB2022-03-15
A Single and Repeat Dose Trial in Participants With Hepatic Impairment (NCT05009680)Galecto Biotech AB2021-09-09
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis (NCT04679870)Galecto Biotech AB2021-06-09
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis (NCT04607655)Galecto Biotech AB2021-03-01
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT03832946)Galecto Biotech AB2019-02-19
A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects (NCT03809052)Galecto Biotech AB2019-01-14

Track Galecto Biotech AB automatically

Every clearance here is in the API, with alerts when new ones post.